Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
---|---|---|---|---|---|
Reversed Phase POSITIVE (Named metabolites) | creatine | 941 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 1361 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 1600 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 91527 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 95587 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 98237 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 100994 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 103372 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 104025 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 106534 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 111158 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 113349 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 114502 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 114841 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 118404 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 118684 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 119139 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 124143 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 124502 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 124589 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 125522 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 125616 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 127015 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 127730 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 130767 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 131437 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 131458 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 132893 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 133033 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 133755 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 136169 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 137471 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 139440 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 140098 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 140511 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 141102 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 141795 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 142627 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 144893 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 146862 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 146904 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 147400 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 150326 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 151253 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 158032 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 160328 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 162616 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 162913 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 163449 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 164356 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 165594 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 165838 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 166104 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 168052 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 169058 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 169636 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 170349 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 170637 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 171971 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 172040 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 172401 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 173899 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 174079 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 175873 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 176068 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 176161 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 176328 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 176418 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 177072 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 177359 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 177370 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 177400 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 177580 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 177952 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 178578 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 178759 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 178799 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 178823 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 179136 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 179370 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 179431 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 179444 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 179468 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 179711 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 179779 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 179996 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 180302 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 180370 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 180406 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 180614 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 180802 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 180897 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 180960 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 181045 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 181121 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 181241 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 181262 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 181495 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 181857 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 181937 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 181960 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 182124 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 182141 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 182327 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 182784 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 183148 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 183887 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 184094 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 184559 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 184857 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 185069 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 185572 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 185826 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 186315 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 186717 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 187011 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 187577 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 188517 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | creatine | 188671 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 189039 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 189793 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 190078 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 191920 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 192333 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 193513 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 193919 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 194733 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 197109 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 198913 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 202584 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 205958 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 207740 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 208537 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 208905 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 209702 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 210345 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 211562 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 211612 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 212436 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 212660 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 213620 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 214654 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 215044 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 216212 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 216319 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 216504 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 218526 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 218769 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 219147 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 219717 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 221498 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 221648 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 221798 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 222464 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 224769 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 225562 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 225759 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 226022 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 227096 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 227153 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 227253 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 228299 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 228696 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 229290 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 230588 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 232011 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 233018 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 235239 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 235257 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 235768 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 236322 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 237121 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 237882 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 238391 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 238652 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 240936 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 241989 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 242162 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 243877 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 245937 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 248610 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 250480 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 251298 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 252038 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 253938 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 254353 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 254651 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 254658 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 255013 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 255250 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 256659 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 257565 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 260665 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 262181 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 262363 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 262704 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 262719 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | creatine | 267205 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 269977 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | creatine | 270583 | Peak area normalized | Sample | male |
Return to search page